Tandy Aye

Publication Details

  • Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.

    Wilson DM, Abrams SH, Aye T, Lee PD, Lenders C, Lustig RH, Osganian SV, Feldman HA. Arch Pediatr Adolesc Med. 2010; 164 (2): 116-23

    Metformin has been proffered as a therapy for adolescent obesity, although long-term controlled studies have not been reported.

    PubMedID: 20124139

Stanford Medicine Resources:

Footer Links: